oxonic acid has been researched along with Bone Cancer in 51 studies
Oxonic Acid: Antagonist of urate oxidase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "For a case of recurrent breast cancer with multiple bone metastasis, an oral pyrimidine fluoride-based anti-cancer drug S -1, and zoledronic acid(a third-generation bisphosphonate formulation), were prescribed in experiments to test their efficacy." | 7.79 | [A case of recurrent breast cancer with multiple bone metastasis successfully treated with S-1 and zoledronic acid therapy]. ( Kaneko, M; Murata, T; Yamada, T; Yoshino, H, 2013) |
| "We report a long-term complete response (CR) in a patient with postoperative recurrent breast cancer and bone and pleura metastases after treatment with a combination of S-1 and zoledronic acid." | 7.76 | [Long-term complete response in a patient with breast cancer and bone and pleura metastases after treatment with a combination of S-1 and zoledronic acid]. ( Fujiwara, I; Ichida, M; Matsumoto, M; Mizuta, M; Mizuta, N; Nishiyama, A; Ohashi, M; Sakaguchi, K; Umeda, Y, 2010) |
| "A 59-year-old man diagnosed as gastric cancer with peritonitis carcinomatosa was treated with paclitaxel and TS-1; 60 mg/m(2)/day of paclitaxel was given on days 1 and 8, and 60-80 mg/m(2)/day of TS-1 was given for 2 weeks." | 7.75 | Advanced gastric cancer patient with peritonitis carcinomatosa successfully treated with a combination therapy of paclitaxel and TS-1, but relapsed with multiple bone metastasis and died from rapidly progressive meningitis carcinomatosa--advanced gastric ( Hasegawa, K; Hirono, H; Shibasaki, K; Soga, K; Watanabe, T; Yoneoka, Y, 2009) |
| "For a case of recurrent breast cancer with multiple bone metastasis, an oral pyrimidine fluoride-based anti-cancer drug S -1, and zoledronic acid(a third-generation bisphosphonate formulation), were prescribed in experiments to test their efficacy." | 3.79 | [A case of recurrent breast cancer with multiple bone metastasis successfully treated with S-1 and zoledronic acid therapy]. ( Kaneko, M; Murata, T; Yamada, T; Yoshino, H, 2013) |
| "We report a long-term complete response (CR) in a patient with postoperative recurrent breast cancer and bone and pleura metastases after treatment with a combination of S-1 and zoledronic acid." | 3.76 | [Long-term complete response in a patient with breast cancer and bone and pleura metastases after treatment with a combination of S-1 and zoledronic acid]. ( Fujiwara, I; Ichida, M; Matsumoto, M; Mizuta, M; Mizuta, N; Nishiyama, A; Ohashi, M; Sakaguchi, K; Umeda, Y, 2010) |
| "A 59-year-old man diagnosed as gastric cancer with peritonitis carcinomatosa was treated with paclitaxel and TS-1; 60 mg/m(2)/day of paclitaxel was given on days 1 and 8, and 60-80 mg/m(2)/day of TS-1 was given for 2 weeks." | 3.75 | Advanced gastric cancer patient with peritonitis carcinomatosa successfully treated with a combination therapy of paclitaxel and TS-1, but relapsed with multiple bone metastasis and died from rapidly progressive meningitis carcinomatosa--advanced gastric ( Hasegawa, K; Hirono, H; Shibasaki, K; Soga, K; Watanabe, T; Yoneoka, Y, 2009) |
| "Synchronous bone metastases from early gastric cancer are extremely rare, and a good outcome was achieved in the present case through induction chemotherapy." | 2.50 | [A case of early gastric cancer with multiple synchronous bone metastases treated complete response with S-1+CDDP]. ( Iwanaga, T; Iwasaki, Y; Ohashi, M; Oohinata, R; Takishita, C; Yajima, K, 2014) |
| "We diagnosed advanced gastric cancer with disseminated carcinomatosis of the bone marrow and multiple bone metastasis." | 2.47 | [A very elderly case of advanced gastric cancer with disseminated carcinomatosis of bone marrow and multiple bone metastasis, diagnosed by extremely elevated serum alkaline phosphatase levels, and treated with low-dose S-1 to avoid disseminated intravascu ( Ashida, C; Higashida, A; Kawara, F; Kondo, T; Mamori, S; Okutani, T; Onishi, K; Takeda, A; Yamada, H, 2011) |
| "We report a rare case of recurrence with bone metastasis from early gastric cancer." | 1.42 | [A Case of Bone Metastasis from Early Gastric Cancer after a Five-Year Disease-Free Interval Following Gastrectomy]. ( Hamakawa, T; Hoshino, H; Ikeda, N; Kamigaki, S; Kawase, T; Kimura, Y; Makari, Y; Mikami, J; Munakata, S; Nakata, K; Ohzato, H; Tsujie, M; Yamamoto, T; Yamamura, J, 2015) |
| "The patient was diagnosed with advanced gastric cancer accompanied by multiple bone metastases, with compression fractures in the thoracolumbar vertebrae as well as distant lymph node metastases." | 1.38 | [A case of advanced gastric cancer with multiple bone metastases and distant lymph node metastases successfully treated by S-1/CDDP combination chemotherapy]. ( Chiba, T; Fujiwara, H; Koeda, K; Mitomo, S; Sugai, T; Takahashi, M; Uesugi, N; Wakabayashi, G, 2012) |
| "Advanced gastric cancer (AGC) accompanied by disseminated intravascular coagulation(DIC)has a poor prognosis, and has no established therapy." | 1.38 | [A case of advanced gastric cancer with multiple bone metastases and disseminated intravascular coagulation successfully treated by combination chemotherapy of S-1 plus docetaxel]. ( Harita, S; Kiguchi, T; Kimura, K; Kubo, T; Mannami, T; Masunari, T; Nakata, Y; Ninomiya, K; Okada, T; Seno, S; Sezaki, N; Sonobe, H; Suzuki, Y; Tamura, T, 2012) |
| " To the best of our knowledge, cases of EGC combined with metachronous osteosclerotic multiple bone and bone marrow metastases that respond to chemoradiotherapy are very rare." | 1.37 | Early gastric cancer combined with multiple metachronous osteosclerotic bone and bone marrow metastases that responded to chemoradiotherapy. ( Chiba, F; Kiyozaki, H; Konishi, F; Saito, M; Shuto, C; Takata, O; Yamada, S; Yoshida, T, 2011) |
| "We report a case of breast carcinoma with repeated recurrences in the right bone." | 1.37 | [A case of repeated bone metastases of breast carcinoma successfully treated by S-1 chemotherapy]. ( Kinoshita, S; Kyoda, S; Morikawa, T; Okamoto, T; Takeyama, H; Uchida, K; Yamashita, A, 2011) |
| "A 49-year-old female with advanced gastric cancer complicated with peritoneal dissemination underwent distal gastrectomy, and thereafter she was treated with a combined chemotherapy of S-1 and paclitaxel for 5 months, followed by treatment with S-1 alone." | 1.36 | [A case of S-1-resistant gastric cancer with multiple bone metastases and disseminated intravascular coagulation--effective treatment by combined chemotherapy with CDDP and CPT-11]. ( Kitagawa, M; Koh, T; Kondo, Y; Nakagawa, N; Nanri, M; Oguro, A; Yamasaki, J, 2010) |
| "Though chronic hepatitis C was pointed out before, it had been left untreated for about 5 years." | 1.35 | [A case of advanced hepatocarcinoma responding to combination therapy of S-1 and PEG-IFN]. ( Ichikawa, M; Iwakawa, K; Matsumoto, T; Miyauchi, S; Seike, H; Tanaka, Y; Tanisaka, Y; Tsubouchi, E, 2009) |
| "We diagnosed disseminated carcinomatosis of bone marrow by gastric cancer." | 1.35 | [A case of advanced gastric cancer with disseminated carcinomatosis of bone marrow treated by S-1 and CDDP]. ( Fujishima, Y; Fukuda, T; Fukunaga, H; Iwai, M; Koide, M; Miura, M; Yoneda, R, 2009) |
| "Pancreas cancer or gallbladder cancer was suspected by CT, and a high tumor marker score (CA19-9 18,625 U/mL, DUPAN-II 15,000 U/ mL elevations were acknowledged)." | 1.35 | [Marked effect of combination chemotherapy with tegafur-gimeracil-oteracil potassium and gemcitabine on a suspected case of pancreas cancer or gallbladder cancer metastasis to bone: further diagnosis of disseminated carcinomatosa of bone marrow recurrence ( Aoyama, I; Arai, O; Doi, A; Hata, T; Hirao, K; Jinno, A; Katayama, S; Kikuchi, O; Kiyosuke, Y; Maeda, Y; Matsueda, K; Miyoshi, M; Mouri, H; Sakai, A; Tanabe, W; Terashima, Y; Tsuji, Y; Yamamoto, H; Yamamoto, N, 2008) |
| "She was diagnosed as remnant gastric cancer with multiple bone metastasis and peritoneal dissemination." | 1.33 | [A case of remnant gastric cancer with multiple bone metastasis and peritoneal dissemination; efficacy of combination therapy of docetaxel and TS-1]. ( Hamai, Y; Hihara, J; Tanabe, K; Toge, T; Ukon, K; Yoshida, K, 2005) |
| "Endoscopic findings revealed type 3 gastric cancer." | 1.33 | [A case of gastric cancer with DIC caused by multiple bone metastases treated with TS-1]. ( Fujishiro, R; Ichinose, T; Naruse, Y; Sakamoto, R; Yamazaki, A, 2006) |
| "We report a rare patient with a DPD deficiency." | 1.33 | [A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency]. ( Arai, K; Hashimoto, T; Hiruma, K; Iwasaki, Y; Matsumoto, H; Saze, Z; Takahashi, K; Yamaguchi, T; Yamashita, Y; Yasutome, M, 2006) |
| "We report a 48-year-old male with gastric cancer who was suffering from acute onset of DIC due to multiple bone metastases." | 1.32 | [A patient with gastric cancer complicated with severe DIC and multiple bone metastasis showing a high response to combination of TS-1 and CDDP]. ( Fujitani, K; Hirao, M; Kida, H; Tsujinaka, T; Yoshioka, S, 2003) |
| "A standard treatment for hepatocellular carcinoma with extrahepatic metastasis is not established and chemotherapy is ineffective." | 1.32 | [A case of hepatocellular carcinoma with bone metastasis responding to concurrent TS-1/low-dose cisplatin (CDDP) therapy and radiotherapy]. ( Aozasa, S; Fujino, K; Hase, K; Ito, H; Okada, K; Shikina, A; Suganuma, T; Tanaka, M; Terauchi, R; Tsuda, T; Utsunomiya, K, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 26 (50.98) | 29.6817 |
| 2010's | 25 (49.02) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, N | 1 |
| Karayama, M | 1 |
| Inui, N | 1 |
| Yasui, H | 1 |
| Hozumi, H | 1 |
| Suzuki, Y | 2 |
| Furuhashi, K | 1 |
| Fujisawa, T | 1 |
| Enomoto, N | 1 |
| Nakamura, Y | 1 |
| Inami, N | 1 |
| Matsuura, S | 1 |
| Kaida, Y | 1 |
| Uto, T | 1 |
| Matsui, T | 1 |
| Asada, K | 1 |
| Matsuda, H | 1 |
| Fujii, M | 3 |
| Toyoshima, M | 1 |
| Suda, T | 1 |
| Murata, T | 1 |
| Yoshino, H | 1 |
| Kaneko, M | 1 |
| Yamada, T | 1 |
| Imataka, H | 1 |
| Sato, A | 1 |
| Hamada, K | 1 |
| Takeda, N | 1 |
| Nemoto, H | 1 |
| Takishita, C | 1 |
| Yajima, K | 1 |
| Iwasaki, Y | 2 |
| Ohashi, M | 2 |
| Iwanaga, T | 1 |
| Oohinata, R | 1 |
| Kimura, Y | 1 |
| Makari, Y | 1 |
| Mikami, J | 1 |
| Kawase, T | 1 |
| Hamakawa, T | 1 |
| Hoshino, H | 1 |
| Nakata, K | 1 |
| Yamamoto, T | 1 |
| Yamamura, J | 1 |
| Kamigaki, S | 1 |
| Ikeda, N | 1 |
| Tsujie, M | 1 |
| Munakata, S | 1 |
| Ohzato, H | 1 |
| Senoo, S | 1 |
| Mannami, T | 2 |
| Tamura, T | 2 |
| Fujiwara, N | 1 |
| Ikeda, G | 1 |
| Komoda, M | 1 |
| Ohtawa, Y | 1 |
| Fujimoto, Y | 1 |
| Sato, N | 1 |
| Kambara, T | 1 |
| Waku, T | 1 |
| Kenmotsu, M | 1 |
| Kurimoto, E | 1 |
| Okada, T | 2 |
| Harita, S | 2 |
| Sonobe, H | 2 |
| Ina, K | 1 |
| Kataoka, T | 1 |
| Takeuchi, Y | 1 |
| Fukuoka, T | 1 |
| Miwa, T | 1 |
| Nishio, T | 1 |
| Furuta, R | 1 |
| Masaki, A | 1 |
| Mori, F | 1 |
| Kayukawa, S | 1 |
| Nagao, S | 1 |
| Ando, T | 1 |
| Goto, H | 1 |
| Lee, JL | 2 |
| Kang, YK | 2 |
| Kang, HJ | 1 |
| Lee, KH | 1 |
| Zang, DY | 1 |
| Ryoo, BY | 2 |
| Kim, JG | 1 |
| Park, SR | 1 |
| Kang, WK | 1 |
| Shin, DB | 1 |
| Ryu, MH | 2 |
| Chang, HM | 2 |
| Kim, TW | 2 |
| Baek, JH | 1 |
| Min, YJ | 1 |
| Ito, Y | 1 |
| Osaki, Y | 1 |
| Tokudome, N | 1 |
| Sugihara, T | 1 |
| Takahashi, S | 1 |
| Iwase, T | 1 |
| Hatake, K | 1 |
| Watanabe, T | 1 |
| Hirono, H | 1 |
| Hasegawa, K | 1 |
| Soga, K | 1 |
| Shibasaki, K | 1 |
| Yoneoka, Y | 1 |
| Kaira, K | 1 |
| Yanagitani, N | 1 |
| Sunaga, N | 1 |
| Imai, H | 1 |
| Utsugi, M | 1 |
| Kawata, T | 1 |
| Hisada, T | 1 |
| Shimizu, K | 1 |
| Ishizuka, T | 1 |
| Mori, M | 2 |
| Tanisaka, Y | 1 |
| Seike, H | 1 |
| Matsumoto, T | 2 |
| Tanaka, Y | 1 |
| Tsubouchi, E | 1 |
| Miyauchi, S | 1 |
| Iwakawa, K | 1 |
| Ichikawa, M | 1 |
| Tomita, K | 1 |
| Nishijima, W | 1 |
| Tsukuda, M | 1 |
| Hasegawa, Y | 1 |
| Ishitoya, J | 1 |
| Yamane, H | 1 |
| Homma, A | 1 |
| Tomita, T | 1 |
| Fujishima, Y | 1 |
| Yoneda, R | 1 |
| Iwai, M | 1 |
| Fukunaga, H | 1 |
| Miura, M | 1 |
| Koide, M | 1 |
| Fukuda, T | 1 |
| Kitagawa, M | 1 |
| Oguro, A | 1 |
| Kondo, Y | 1 |
| Koh, T | 1 |
| Yamasaki, J | 1 |
| Nanri, M | 1 |
| Nakagawa, N | 1 |
| Mizuta, N | 2 |
| Sakaguchi, K | 2 |
| Mizuta, M | 2 |
| Ichida, M | 1 |
| Umeda, Y | 1 |
| Nishiyama, A | 1 |
| Matsumoto, M | 1 |
| Fujiwara, I | 2 |
| Hata, T | 2 |
| Fujino, S | 1 |
| Yanagawa, T | 1 |
| Kitahara, T | 1 |
| Munakata, K | 1 |
| Watanabe, N | 1 |
| Takamoto, K | 1 |
| Miyake, M | 1 |
| Kawanishi, K | 1 |
| Shimizu, J | 1 |
| Ikeda, K | 1 |
| Fujita, J | 1 |
| Iwazawa, T | 1 |
| Akagi, K | 1 |
| Douno, K | 1 |
| Kitada, M | 1 |
| Shimano, T | 1 |
| Yamada, D | 1 |
| Wada, H | 1 |
| Kobayashi, S | 1 |
| Marubashi, S | 1 |
| Eguchi, H | 1 |
| Takeda, Y | 1 |
| Tanemura, M | 1 |
| Umeshita, K | 1 |
| Doki, Y | 1 |
| Nagano, H | 1 |
| Hara, F | 1 |
| Kiyoto, S | 1 |
| Takahashi, M | 3 |
| Takabatake, D | 1 |
| Takashima, S | 2 |
| Aogi, K | 1 |
| Ohsumi, S | 1 |
| Ikarashi, M | 1 |
| Wakabayashi, K | 2 |
| Omori, K | 1 |
| Ishibashi, Y | 1 |
| Aoki, M | 1 |
| Iwama, A | 1 |
| Itoh, Y | 1 |
| Schultheis, B | 1 |
| Strumberg, D | 1 |
| Bergmann, L | 1 |
| Graeven, U | 1 |
| Hanauske, AR | 1 |
| Lipp, R | 1 |
| Schuette, J | 1 |
| Saito, K | 1 |
| Scigalla, P | 1 |
| Scheulen, ME | 1 |
| Tamada, S | 1 |
| Sagara, Y | 3 |
| Baba, S | 1 |
| Yotsumoto, D | 1 |
| Matsukata, A | 1 |
| Andou, M | 1 |
| Rai, Y | 1 |
| Nakamoto, Y | 1 |
| Kayata, Y | 1 |
| Kikawa, Y | 1 |
| Ogata, M | 1 |
| Yamamoto, M | 1 |
| Saito, M | 1 |
| Kiyozaki, H | 1 |
| Chiba, F | 1 |
| Takata, O | 1 |
| Yoshida, T | 1 |
| Shuto, C | 1 |
| Yamada, S | 1 |
| Konishi, F | 1 |
| Nishida, T | 1 |
| Nakano, S | 1 |
| Shida, T | 1 |
| Ootsuka, T | 1 |
| Ogasawara, T | 1 |
| Nakajima, F | 1 |
| Matsuoka, K | 1 |
| Ogawa, T | 1 |
| Nomura, H | 1 |
| Araya, J | 1 |
| Matsushita, S | 1 |
| Yonekura, K | 1 |
| Mera, K | 1 |
| Kawai, K | 1 |
| Kanekura, T | 1 |
| Takeda, A | 1 |
| Kawara, F | 1 |
| Onishi, K | 1 |
| Higashida, A | 1 |
| Mamori, S | 1 |
| Ashida, C | 1 |
| Okutani, T | 1 |
| Yamada, H | 1 |
| Kondo, T | 1 |
| Takeyama, H | 1 |
| Kyoda, S | 1 |
| Yamashita, A | 1 |
| Kinoshita, S | 1 |
| Okamoto, T | 1 |
| Uchida, K | 1 |
| Morikawa, T | 1 |
| Koo, DH | 1 |
| Lee, SS | 1 |
| Moon, JH | 1 |
| Mitomo, S | 1 |
| Koeda, K | 1 |
| Fujiwara, H | 1 |
| Chiba, T | 1 |
| Uesugi, N | 1 |
| Sugai, T | 1 |
| Wakabayashi, G | 1 |
| Ninomiya, K | 1 |
| Seno, S | 1 |
| Kimura, K | 1 |
| Kubo, T | 1 |
| Masunari, T | 1 |
| Kiguchi, T | 1 |
| Sezaki, N | 1 |
| Nakata, Y | 1 |
| Uchida, Y | 1 |
| Denno, R | 1 |
| Obama, K | 1 |
| Kinoshita, K | 1 |
| Kanai, M | 1 |
| Takabayashi, A | 1 |
| Yoshioka, S | 1 |
| Tsujinaka, T | 1 |
| Kida, H | 1 |
| Hirao, M | 1 |
| Fujitani, K | 1 |
| Omatsu, T | 1 |
| Ichikawa, H | 1 |
| Kawahito, Y | 1 |
| Ashihara, E | 1 |
| Yamamoto, A | 1 |
| Kadoya, M | 1 |
| Takegami, T | 1 |
| Takanashi, Y | 1 |
| Naito, Y | 1 |
| Yoshida, N | 1 |
| Sugino, S | 1 |
| Yoshikawa, T | 1 |
| Hayashi, S | 1 |
| Masuda, H | 2 |
| Karube, H | 1 |
| Ookame, H | 1 |
| Aoki, H | 1 |
| Sakamoto, N | 1 |
| Tanaka, T | 1 |
| Takayama, T | 1 |
| Suganuma, T | 1 |
| Terauchi, R | 1 |
| Shikina, A | 1 |
| Tanaka, M | 1 |
| Aozasa, S | 1 |
| Utsunomiya, K | 1 |
| Fujino, K | 1 |
| Ito, H | 1 |
| Okada, K | 1 |
| Tsuda, T | 1 |
| Hase, K | 1 |
| Yamashita, N | 1 |
| Shakado, S | 1 |
| Takemoto, R | 1 |
| Nishi, H | 1 |
| Fukumori, K | 1 |
| Fukuizumi, K | 1 |
| Miyahara, T | 1 |
| Sakai, H | 1 |
| Yasumori, K | 1 |
| Muranaka, T | 1 |
| Takami, Y | 1 |
| Saitsu, H | 1 |
| Watanabe, J | 1 |
| Takemura, M | 1 |
| Osugi, H | 1 |
| Lee, S | 1 |
| Nishikawa, T | 1 |
| Fukuhara, K | 1 |
| Iwasaki, H | 1 |
| Tanabe, K | 1 |
| Yoshida, K | 1 |
| Hamai, Y | 1 |
| Ukon, K | 1 |
| Hihara, J | 1 |
| Toge, T | 1 |
| Fujishiro, R | 1 |
| Naruse, Y | 1 |
| Ichinose, T | 1 |
| Yamazaki, A | 1 |
| Sakamoto, R | 1 |
| Hashimoto, T | 1 |
| Arai, K | 1 |
| Saze, Z | 1 |
| Takahashi, K | 1 |
| Yamaguchi, T | 1 |
| Matsumoto, H | 1 |
| Yasutome, M | 1 |
| Hiruma, K | 1 |
| Yamashita, Y | 1 |
| Osaki, T | 1 |
| Takimoto, T | 1 |
| Furukawa, M | 1 |
| Inoue, M | 1 |
| Okumura, M | 1 |
| Niju, T | 1 |
| Kijima, T | 1 |
| Kumagai, T | 1 |
| Yoshida, M | 1 |
| Tachibana, I | 1 |
| Kawase, I | 1 |
| Nakajima, H | 1 |
| Nakatsukasa, K | 1 |
| Kobayashi, A | 1 |
| Hachimine, Y | 1 |
| Sawai, K | 1 |
| Migita, K | 1 |
| Watanabe, A | 1 |
| Sakamoto, C | 1 |
| Nakamura, T | 1 |
| Ohyama, T | 1 |
| Ishikawa, H | 1 |
| Yamamoto, K | 1 |
| Yoneyama, K | 1 |
| Yamada, A | 1 |
| Koshida, Y | 1 |
| Toriumi, F | 1 |
| Murayama, T | 1 |
| Toeda, H | 1 |
| Imazu, Y | 1 |
| Motegi, K | 1 |
| Akamatsu, H | 1 |
| Ooyama, R | 1 |
| Maruyama, S | 1 |
| Iga, N | 1 |
| Shimo, T | 1 |
| Tomii, K | 1 |
| Shoga, K | 1 |
| Kanaya, Y | 1 |
| Yokoyama, N | 1 |
| Nishioka, K | 1 |
| Kobayashi, K | 1 |
| Aoki, T | 1 |
| Hatano, H | 1 |
| Komori, T | 1 |
| Uemura, Y | 1 |
| Kawano, I | 1 |
| Yufu, M | 1 |
| Shien, T | 1 |
| Shimizu, C | 1 |
| Akashi-Tanaka, S | 1 |
| Yonemori, K | 1 |
| Kohno, T | 1 |
| Hojo, T | 1 |
| Ando, M | 1 |
| Katsumata, N | 1 |
| Kinoshita, T | 1 |
| Fujiwara, Y | 1 |
| Sakai, A | 1 |
| Tsuji, Y | 1 |
| Kikuchi, O | 1 |
| Jinno, A | 1 |
| Tanabe, W | 1 |
| Terashima, Y | 1 |
| Maeda, Y | 1 |
| Doi, A | 1 |
| Yamamoto, N | 1 |
| Aoyama, I | 1 |
| Arai, O | 1 |
| Kiyosuke, Y | 1 |
| Katayama, S | 1 |
| Hirao, K | 1 |
| Miyoshi, M | 1 |
| Mouri, H | 1 |
| Matsueda, K | 1 |
| Yamamoto, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Efficacy and Tolerance Between Combination Therapy and Monotherapy as a First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer; Multicenter Randomized Phase 3 Study[NCT02114359] | Phase 3 | 111 participants (Actual) | Interventional | 2014-02-28 | Completed | ||
| Phase III Study of Adjuvant Capecitabine vs Observation Alone in Curatively Resected Stage IB (by AJCC 6th Edition) Gastric Cancer(KCSG ST14-05)[NCT01917552] | Phase 3 | 870 participants (Anticipated) | Interventional | 2013-08-19 | Recruiting | ||
| Randomized Open-label Trial of Dose Dense, Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in Metastatic Breast Cancer and Advanced/Metastatic Gastrointestinal Cancers.[NCT02595320] | Phase 2 | 200 participants (Actual) | Interventional | 2015-10-05 | Active, not recruiting | ||
| Phase III Trial of S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer[NCT01671449] | Phase 3 | 338 participants (Actual) | Interventional | 2012-12-31 | Completed | ||
| Phase Ⅱ Clinical Study of RALOX or CAPOX Combined With Bevacizumab in the First-line Treatment of Advanced Colorectal Cancer[NCT03813641] | Phase 2 | 100 participants (Anticipated) | Interventional | 2019-01-28 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for oxonic acid and Bone Cancer
| Article | Year |
|---|---|
[A case of early gastric cancer with multiple synchronous bone metastases treated complete response with S-1+CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Combinations; | 2014 |
[A very elderly case of advanced gastric cancer with disseminated carcinomatosis of bone marrow and multiple bone metastasis, diagnosed by extremely elevated serum alkaline phosphatase levels, and treated with low-dose S-1 to avoid disseminated intravascu
Topics: Aged, 80 and over; Alkaline Phosphatase; Antimetabolites, Antineoplastic; Bone Marrow Neoplasms; Bon | 2011 |
6 trials available for oxonic acid and Bone Cancer
| Article | Year |
|---|---|
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Bone Neopl | 2019 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2010 |
Efficacy and safety of S-1 in patients with metastatic breast cancer: retrospective review in a single institution.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Drug Combinations; F | 2010 |
Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group).
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Combinations; | 2012 |
Three-week combination chemotherapy with S-1 and cisplatin as first-line treatment in patients with advanced gastric cancer: a retrospective study with 159 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisp | 2012 |
43 other studies available for oxonic acid and Bone Cancer
| Article | Year |
|---|---|
[A case of recurrent breast cancer with multiple bone metastasis successfully treated with S-1 and zoledronic acid therapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphona | 2013 |
[A case of progressive gastric carcinoma accompanied by disseminated carcinomatosis of bone marrow (DCBM)due to bone metastasis, with DIC recovery by administration of S-1 and docetaxel].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Disease Progr | 2013 |
[A Case of Bone Metastasis from Early Gastric Cancer after a Five-Year Disease-Free Interval Following Gastrectomy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Combinations; Female | 2015 |
[HER2-Positive Advanced Gastric Cancer with Disseminated Intravascular Coagulation and Diffuse Bone Marrow Carcinomatosis Successfully Treated with S-1/Trastuzumab Chemotherapy--A Case Report].
Topics: Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Neoplasms; | 2015 |
Pathological complete response induced by the combination therapy of S-1 and 24-h infusion of cisplatin in two cases initially diagnosed as inoperable advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone | 2008 |
Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antimetabolites, Antineoplastic; Bone Neoplasms; Bre | 2009 |
Advanced gastric cancer patient with peritonitis carcinomatosa successfully treated with a combination therapy of paclitaxel and TS-1, but relapsed with multiple bone metastasis and died from rapidly progressive meningitis carcinomatosa--advanced gastric
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Drug Combinations; F | 2009 |
[Effective gemcitabine plus S-1 treatment in elderly non-small cell lung cancer patients with multiple bone metastases].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Non-Sm | 2009 |
[A case of advanced hepatocarcinoma responding to combination therapy of S-1 and PEG-IFN].
Topics: Angiography; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; | 2009 |
[A case of advanced gastric cancer with disseminated carcinomatosis of bone marrow treated by S-1 and CDDP].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplas | 2009 |
[A case of S-1-resistant gastric cancer with multiple bone metastases and disseminated intravascular coagulation--effective treatment by combined chemotherapy with CDDP and CPT-11].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineopl | 2010 |
[Long-term complete response in a patient with breast cancer and bone and pleura metastases after treatment with a combination of S-1 and zoledronic acid].
Topics: Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonate | 2010 |
[Long-term control of sacral metastasis from rectal cancer with S-1 + radiation treatment (RT) and mFOLFOX6 combination therapy--a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Dru | 2010 |
[A long-term survival case of hepatocellular carcinoma with bone metastasis and inferior vena cava tumor thrombus successfully treated with multidisciplinary therapy].
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Thera | 2010 |
[A case of rectal cancer with sacrum metastasis treated with S-1 leading to a complete response].
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Combinations; Female; Humans; Magnetic Resonan | 2011 |
[A patient with of metastatic breast cancer with a well-controlled quality of life using S-1 therapy as first-line chemotherapy].
Topics: Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Drug Combinations; Female; | 2011 |
[A successful case treated with S-1 and zoledronic acid for multiple bone metastasis of breast cancer].
Topics: Antimetabolites, Antineoplastic; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms | 2011 |
Early gastric cancer combined with multiple metachronous osteosclerotic bone and bone marrow metastases that responded to chemoradiotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Ne | 2011 |
[A case of multiple bone metastasis of gastric carcinoma accompanying DIC successfully controlled with combination of S-1 and low-dose CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Disseminated Intravascula | 2011 |
[A case of multiple metastases breast cancer controlled using S-1 as third-line chemotherapy].
Topics: Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Drug Combinations; Female; | 2011 |
Successful treatment of metastatic extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Drug Combinations; | 2011 |
[A case of repeated bone metastases of breast carcinoma successfully treated by S-1 chemotherapy].
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Drug Combinations; Female; Humans | 2011 |
[A case of advanced gastric cancer with multiple bone metastases and distant lymph node metastases successfully treated by S-1/CDDP combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Combinations; Humans | 2012 |
[A case of advanced gastric cancer with multiple bone metastases and disseminated intravascular coagulation successfully treated by combination chemotherapy of S-1 plus docetaxel].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disseminated Intravascular Coa | 2012 |
[A case of recurrent advanced gastric cancer suggesting the efficacy of TS-1 and CDDP combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta; Bone Neoplasms; Chemotherapy, | 2002 |
[A patient with gastric cancer complicated with severe DIC and multiple bone metastasis showing a high response to combination of TS-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Clodronic Acid; Dissemina | 2003 |
[A case of advanced gastric cancer with bone metastases and DIC responding to oral administration of TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Carcinoma, Signet Ring | 2003 |
[A case of advanced gastric cancer with simultaneous multiple bone metastases and double occurrence of disseminated intravascular coagulation successfully controlled with combined chemotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Co | 2004 |
[A case of hepatocellular carcinoma with bone metastasis responding to concurrent TS-1/low-dose cisplatin (CDDP) therapy and radiotherapy].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tumor; B | 2004 |
[A case of hepatocellular carcinoma with bone metastasis treated by TS-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hepatocellular; Cisplatin | 2005 |
[A patient with multiple bone metastases from gastric cancer after an 8-year disease-free interval following gastrectomy].
Topics: Adenocarcinoma; Anastomosis, Roux-en-Y; Antimetabolites, Antineoplastic; Bone and Bones; Bone Neopla | 2005 |
[A case of remnant gastric cancer with multiple bone metastasis and peritoneal dissemination; efficacy of combination therapy of docetaxel and TS-1].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modal | 2005 |
[A case of gastric cancer with DIC caused by multiple bone metastases treated with TS-1].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Combined Modality Therapy; Di | 2006 |
[A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency].
Topics: Adult; Anorexia; Antimetabolites, Antineoplastic; Bone Neoplasms; Cerebral Hemorrhage; Dihydropyrimi | 2006 |
[Clinical efficacy of TS-1 in refractory bone recurrence of a postoperative squamous lung cancer patient].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Bone Neoplasms; Carcinoma, Squamous Cell; Com | 2006 |
[A case of multi-drug resistant recurrent breast cancer with multiple bone metastasis responding to TS-1 and trastuzumab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2006 |
[A case of multiple bone metastases from gastric cancer treated with combination chemotherapy of S-1 and CDDP].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Admi | 2007 |
[A patient with pulmonary metastasis from breast cancer after surgery who responded to S-1].
Topics: Adenocarcinoma; Antigens, Tumor-Associated, Carbohydrate; Antimetabolites, Antineoplastic; Biomarker | 2007 |
[A case of gastric cancer with multiple bone metastasis that responded to S-1 with low-dose cis-platinum].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Combinations; | 2008 |
[Two patients of progressive gastric cancer accompanied by disseminated carcinomatosis of bone marrow due to bone metastasis with DIC successfully controlled by combination of S-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Disease Progression; Drug | 2007 |
[A patient with gastric cancer complicated with multiple spinal bone metastases showing a complete remission to combination of S-1 and CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Cisplatin; | 2008 |
Clinical efficacy of S-1 in pretreated metastatic breast cancer patients.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms | 2008 |
[Marked effect of combination chemotherapy with tegafur-gimeracil-oteracil potassium and gemcitabine on a suspected case of pancreas cancer or gallbladder cancer metastasis to bone: further diagnosis of disseminated carcinomatosa of bone marrow recurrence
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Bone Marrow Neoplasms; Bone Neoplasms | 2008 |